BSCL2 and Hepatic steatosis: For instance, in lipodystrophic A-ZIP/F-1 mice, AT significantly reduces hyperglycemia and insulin resistance (30, 31); in lipodystrophic Seipin KO mice, AT also remarkably reverses dyslipidemia, hepatic steatosis, and insulin resistance (19, 20).